https://orcid.org/0000-0002-4064-3030
References
- Hoetzenecker W, Nägeli M, Mehra ET, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016;38(1):75–86. doi:10.1007/s00281-015-0540-2
- Chu C-Y. Drug Eruptions: a great imitators. Clin Dermatol. 2020;38(2):193–207. doi:10.1016/j.clindermatol.2019.10.005
- Motofei IG, Rowland DL, Tampa M, et al. Finasteride and androgenic alopecia; from therapeutic options to medical implications. J Dermatolog Treat. 2020;31(4):415–421. doi:10.1080/09546634.2019.1595507
- Tresch S, Cozzio A, Kamarashev J, et al. T cell–mediated acute localized exanthematous pustulosis caused by finasteride. J Allergy Clin Immunol. 2012;129(2):589–594. doi:10.1016/j.jaci.2011.07.033
- Moreno-Fernandez A, Mira Laguarda JM, Ruiz-Hornillos FJ, et al. Urticarial rush due to finasteride. Allergy. 2010;65(3):405–406. doi:10.1111/j.1398-9995.2009.02165.x
- Lear JT, Byrne JP. Finasteride-related cutaneous vaculitis. Postgrad Med J. 1996;72(844):127. doi:10.1136/pgmj.72.844.127-a
- Al Hammadi A, Asai Y, Patt ML, et al. Erythema annulare centrifugum secondary to treatment with finasteride. J Drugs Dermatol. 2007;6(4):460–463.
- Oyama N, Kaneko F. Solitary fixed drug eruption caused by finasteride. J Am Acad Dermatol. 2009;60(1):168–169. doi:10.1016/j.jaad.2008.07.037
- Yamada T. Photosensitivity reaction induced by finasteride. J Gen Fam Med. 2021;23(3):185–186. doi:10.1002/jgf2.510